The LDL receptor played an important role in the RAS/RAF/MAPK (MEK)/ERK signaling cascade, and synergy between LDL-mediated receptor uptake and BRAF may lead to a worse prognosis in thyroid cancer patients [42]. The gene discussed is MAP2K7; the disease is thyroid cancer.